Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 230

The DOI matches its Crossref record.

The validity of the mortality to incidence ratio as a proxy for site-specific cancer survival

Open access
Asadzadeh Vostakolaei, Fatemeh, Karim-Kos, Henrike E., Janssen-Heijnen, Maryska L. G., Visser, Otto, Verbeek, André L. M., Kiemeney, Lambertus A. L. M. · 2011 · European Journal of Public Health

Abstract

BACKGROUND: The complement of the cancer mortality to incidence ratio [1-(M/I)] has been suggested as a valid proxy for 5-year relative survival. Whether this suggestion holds true for all types of cancer has not yet been adequately evaluated. METHODS: We used publicly available databases of cancer incidence, cancer mortality and relative survival to correlate relative survival estimates and 1-(M/I) estimates from Denmark, Finland, Iceland, Norway, Sweden, the USA and the Netherlands. We visually examined for which tumour sites 5-year relative survival cannot simply be predicted by the 1-(M/I) and evaluated similarities between countries. RESULTS: Country-specific linear regression analyses show that there is no systematic bias in predicting 5-year relative survival by 1-(M/I) in five countries. There is a small but significant systematic underestimation of survival from prognostically poor tumour sites in two countries. Furthermore, the 1-(M/I) overestimates survival from oral cavity and liver cancer with >10% in at least two of the seven countries. By contrast, the proxy underestimates survival from soft tissue, bone, breast, prostate and oesophageal cancer, multiple myeloma and leukaemia with >10% in at least two of the seven countries. CONCLUSION: The 1-(M/I) is a good approximation of the 5-year relative survival for most but not all tumour sites.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/eurpub/ckq120

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 230

Metadata

Authors
Asadzadeh Vostakolaei, F., Karim-Kos, H. E., Janssen-Heijnen, M. L. G., Visser, O., Verbeek, A. L. M., & Kiemeney, L. A. L. M.
Venue
European Journal of Public Health
Published
2010-09-02
Volume
21
Issue
5
Pages
573-577
ISSN
  • 1101-1262 (ISSN-L)
  • 1464-360X
OpenAlex
W2095823053
Cited by
230
References
0
FWCI
2.56
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The validity of the mortality to incidence ratio as a proxy for site-specific cancer survival. https://app.cochat.ai/papers/10.1093/eurpub/ckq120
The paper
Asadzadeh Vostakolaei, F., Karim-Kos, H. E., Janssen-Heijnen, M. L. G., Visser, O., Verbeek, A. L. M., & Kiemeney, L. A. L. M. (2011). The validity of the mortality to incidence ratio as a proxy for site-specific cancer survival. European Journal of Public Health. https://doi.org/10.1093/eurpub/ckq120

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.